A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers. / Oranje, Bob; Wienberg, Malene; Glenthøj, Birte Yding.

I: Psychiatry Research, Bind 186, 2011, s. 431-436.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Oranje, B, Wienberg, M & Glenthøj, BY 2011, 'A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers', Psychiatry Research, bind 186, s. 431-436. https://doi.org/10.1016/j.psychres.2010.09.019, https://doi.org/10.1016/j.psychres.2010.09.019

APA

Oranje, B., Wienberg, M., & Glenthøj, B. Y. (2011). A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers. Psychiatry Research, 186, 431-436. https://doi.org/10.1016/j.psychres.2010.09.019, https://doi.org/10.1016/j.psychres.2010.09.019

Vancouver

Oranje B, Wienberg M, Glenthøj BY. A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers. Psychiatry Research. 2011;186:431-436. https://doi.org/10.1016/j.psychres.2010.09.019, https://doi.org/10.1016/j.psychres.2010.09.019

Author

Oranje, Bob ; Wienberg, Malene ; Glenthøj, Birte Yding. / A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers. I: Psychiatry Research. 2011 ; Bind 186. s. 431-436.

Bibtex

@article{ef7a236a34c6481e858c3e44f4c12f29,
title = "A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers",
abstract = "Early mechanisms to limit the input of sensory information to higher brain areas are important for a healthy individual. In previous studies, we found that a low dose of 10mg escitalopram (SSRI) disrupts habituation, without affecting sensory and sensorimotor gating in healthy volunteers. In the current study a higher dose of 15mg was used. The hypothesis was that this higher dose of escitalopram would not only disrupt habituation, but also sensory and sensorimotor gating. Twenty healthy male volunteers received either placebo or 15mg escitalopram, after which they were tested in a P50 suppression, and a habituation and prepulse inhibition (PPI) of the startle reflex paradigm. Escitalopram significantly decreased P50 suppression and habituation, but had no effect on PPI. The results indicate that habituation and sensory gating are disrupted by increased serotonergic activity, while sensorimotor gating seems relatively insensitive to such a rise. Since the patients who are frequently treated with SSRIs (patients with schizophrenia and affective disorders) might already suffer from disrupted sensory gating and habituation, the current results call for caution in the determination of a proper dose.",
author = "Bob Oranje and Malene Wienberg and Glenth{\o}j, {Birte Yding}",
note = "Copyright {\textcopyright} 2010 Elsevier Ltd. All rights reserved.",
year = "2011",
doi = "10.1016/j.psychres.2010.09.019",
language = "English",
volume = "186",
pages = "431--436",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",

}

RIS

TY - JOUR

T1 - A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers

AU - Oranje, Bob

AU - Wienberg, Malene

AU - Glenthøj, Birte Yding

N1 - Copyright © 2010 Elsevier Ltd. All rights reserved.

PY - 2011

Y1 - 2011

N2 - Early mechanisms to limit the input of sensory information to higher brain areas are important for a healthy individual. In previous studies, we found that a low dose of 10mg escitalopram (SSRI) disrupts habituation, without affecting sensory and sensorimotor gating in healthy volunteers. In the current study a higher dose of 15mg was used. The hypothesis was that this higher dose of escitalopram would not only disrupt habituation, but also sensory and sensorimotor gating. Twenty healthy male volunteers received either placebo or 15mg escitalopram, after which they were tested in a P50 suppression, and a habituation and prepulse inhibition (PPI) of the startle reflex paradigm. Escitalopram significantly decreased P50 suppression and habituation, but had no effect on PPI. The results indicate that habituation and sensory gating are disrupted by increased serotonergic activity, while sensorimotor gating seems relatively insensitive to such a rise. Since the patients who are frequently treated with SSRIs (patients with schizophrenia and affective disorders) might already suffer from disrupted sensory gating and habituation, the current results call for caution in the determination of a proper dose.

AB - Early mechanisms to limit the input of sensory information to higher brain areas are important for a healthy individual. In previous studies, we found that a low dose of 10mg escitalopram (SSRI) disrupts habituation, without affecting sensory and sensorimotor gating in healthy volunteers. In the current study a higher dose of 15mg was used. The hypothesis was that this higher dose of escitalopram would not only disrupt habituation, but also sensory and sensorimotor gating. Twenty healthy male volunteers received either placebo or 15mg escitalopram, after which they were tested in a P50 suppression, and a habituation and prepulse inhibition (PPI) of the startle reflex paradigm. Escitalopram significantly decreased P50 suppression and habituation, but had no effect on PPI. The results indicate that habituation and sensory gating are disrupted by increased serotonergic activity, while sensorimotor gating seems relatively insensitive to such a rise. Since the patients who are frequently treated with SSRIs (patients with schizophrenia and affective disorders) might already suffer from disrupted sensory gating and habituation, the current results call for caution in the determination of a proper dose.

U2 - 10.1016/j.psychres.2010.09.019

DO - 10.1016/j.psychres.2010.09.019

M3 - Journal article

C2 - 20971512

VL - 186

SP - 431

EP - 436

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

ER -

ID: 34046194